		Technical Data
A0857-12A	APOA1BP (Apolipoprotein A-I-binding Protein, AI-BP, YjeF N-terminal Domain-containing Protein 1, YjeF_N1, AIBP, YJEFN1)

Description:
APOA1BP interacts with apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoproteins (HDLs). It is secreted into some bodily fluids, and its synthesis and secretion are stimulated in vitro by incubating cells with apoA-I.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 0.5-1.5ug/ml
Optimal dilutions to be determined by the researcher.

Positive Control:
Human Heart lysate

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Type	Isotype	Clone	Grade
Pab	IgG		Affinity Purified

Size		Storage	Shipping	Source	Host
100ug		-20°C	Blue Ice	Human	Goat

Concentration:

~0.5mg/ml

Immunogen:

Synthetic peptide corresponding to PPYPDTECVYRLQ, from the C-Terminus of the protein sequence according to NP_658985.2.

Purity:

Purified by immunoaffinity chromatography.

Form

Supplied as a liquid in Tris saline, 0.02% sodium azide, pH7.3, 0.5% BSA.

Specificity:

Recognizes human APOA1BP. Species sequence homology: bovine, canine, mouse, rat, porcine.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.